Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-03-01 to 2024-06-01
Current total value of award: $15400
Description: NIDDK / IV ISOTOPE 6,6 D2GLUCOSE